Please note: AABB reserves the right to make updates to this program.
Thursday, March 5, 2020
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 20EL-513 (see program format numbers below under Registration)
Educational Track: Quality Education
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Directors, Donor Recruitment Staff, Hospital Blood Banks, Managers/Supervisors, Medical Directors, Nurses, Research Scientists, Scientists, Students (MD, MT, SBB)
Teaching Level: Basic to Intermediate
Director: Srijana Rajbhandary, MPH, Associate Director, AABB, Bethesda, MD
Moderator: Nancy L. Van Buren, MD, Medical Director, Innovative Blood Resources, Saint Paul, MN
Speakers: Mary J. Townsend, MD, Medical Director, Vitalant, Scottsdale, AZ; Mindy Goldman, MD, Medical Director, Donor & Clinical Services, Canadian Blood Services, Ottawa, Canada
After participating in this educational activity, participants should be able to:
- Give example(s) of situations where decision to either defer or accept a donor is difficult to make.
- Discuss donor eligibility issues in situations with no specific guidance (e.g. athletes, donors with certain medical conditions and disabilities).
- Describe best practices to ensure donor safety among such uncommon donors.
Have you had difficulty with donor deferral in situations where there is no specific guidance? Blood donation among athletes, medication deferrals, donors who underwent the new stem cell and RPR treatments for orthopedic and cosmetic purposes, donors with medical conditions (e.g. cardiac disease) and donors with disabilities (e.g. wheel chair use). The list can go on-and-on. This eCast will go over donor eligibility criteria to ensure donor safety and cover such difficult situations. Participants will also be invited to list their most troublesome eligibility issues to be addressed during the program.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Continuing Education Credit
AABB estimates both the live and on-demand version of this eCast each to be eligible for 1.5 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Mindy Goldman is a clinical hematologist with a fellowship in Transfusion Medicine. She has been active in many facets of transfusion medicine in Canada, including optimization of the donor screening process and donor and recipient safety issues. She is currently the Medical Director of Donor and Clinical Services at Canadian Blood Services.
Dr. Mary Townsend serves as the Senior Medical Director, National Office at Vitalant in Scottsdale, AZ. Born in Nocona, Texas, Mary earned her bachelor’s degree in Chemistry and her master’s degree in Physical Chemistry prior to attending medical school at UT Southwestern in Dallas, TX. She trained in Obstetrics and Gynecology at the University of Pennsylvania and completed her residency in Clinical Pathology at the Medical College of Pennsylvania. Mary has spent her career focusing on the care and feeding of donors, for whom she has an abiding passion. She was an inaugural member of the AABB Task Force to redesign the uniform donor questionnaire, serving as its second chair. She chaired both the America’s Blood Centers’ Scientific, Medical, Technical and Quality committee and the ABC Donor Adverse Event committee. She has been a member of the AABB Donor Biovigilance Working Group since its inception and was one of three centers to pilot the DonorHART Biovigilance system. She has been an editor of Notify Library since 2015, focusing on donor adverse events and infectious events in recipients.